GeisterBio

GeisterBio revolutionizes cardiac healthcare by developing fully bioprinted, patient-specific hearts. Using advanced biofabrication and proprietary biomaterials, we address the global shortage of donor hearts and eliminate transplant rejection. Our technology combines tissue engineering, AI-driven organ design, and regenerative medicine to produce functional, patient-matched organs on demand.

GeisterBio’s mission is to end the heart donor crisis by offering a scalable, ethical, and personalized alternative to traditional transplantation.

Participation: FACTORY+ #10 (AplusB-Program) 2025/26